Mechanisms of deficient interferon‐γ production in atopic diseases

Publisher Website
Google Scholar
Abstract
The mechanisms responsible for an imbalanced cytokine response in atopic diseases are still not understood. While impaired interferon-gamma (IFN-γ) production may be the result of a pathological T-cell/antigen-presenting cell (APC) interaction, evidence was provided that the T cell itself may have an intrinsic defect to produce IFN-γ. To clarify whether impaired IFN-γ production by T cells from patients with atopic dermatitis (AD) represents an intrinsic defect in producing IFN-γ. Effector T cells were generated from CD4+ CD45RA+-naive precursors from patients with AD and healthy control individuals by activation with anti-CD3+ anti-CD28 MoAbs. Following restimulation, IFN-γ production was measured by ELISA and flow cytometry. IFN-γ production by atopic T cells was decreased compared with healthy T cells. IL-12 present at priming or high doses of IL-2 during the culture period, even in the absence of IL-12, completely restored IFN-γ production. Conversion of naive CD45RA+ to CD45R0+ effector cells did not differ between atopic and healthy donors' T cells. Impaired IFN-γ production by T cells from atopic individuals is not the result of an intrinsic, genetically fixed, defect to produce sufficient amounts of IFN-γ. The data provides evidence that correction of an impaired TH1 response in AD may be successful at the precursor T cell level.

This publication has 42 references indexed in Scilit: